MMizuho MMeta · META

Mizuho Lowers Meta Price Target to $750

Jul 30, 2026· 1 min read· Reproduced verbatim
Rating
Buy
Price target
$750
Previous
$835
Implied upside
+28%

Mizuho analyst Lloyd Walmsley lowered the price target on Meta Platforms Inc.

(NASDAQ: META) to $750 (from $835) while maintaining an Outperform rating.

“We are buyers on the dip and expect near-term compute monetization product.

Meta failed to deliver on definitive plans to sell compute, today.

But we think (1) they delivered across the board elsewhere, in our view, and (2) suggested on AI monetization they would have “more to share on all of this soon”.

Ad revenue ex-FX growth accelerated 60bps on the two-year stack and the high end of the rev guide implies 4ppts of sequential acceleration in 3Q.

On the cost side, they only raised ’26 guide to incorporate a legal fine in 2Q, and did not raise the high end of capex, so no impact on ’27.

We expect several new monetization paths for AI including selling compute, a new coding product, selling access via API, and scaling Business AIs (largely not in #s).

We trim our PT to $750 on peer multiple contraction.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.